Systematic screening of gender violence and domestic violence among HIV-positive patients: the VIHOLETA study.


Journal

AIDS care
ISSN: 1360-0451
Titre abrégé: AIDS Care
Pays: England
ID NLM: 8915313

Informations de publication

Date de publication:
10 2023
Historique:
medline: 7 8 2023
pubmed: 29 9 2022
entrez: 28 9 2022
Statut: ppublish

Résumé

We conducted a multicentre observational study in people living with HIV (PLHIV) on antiretroviral therapy in Alicante (Spain) from 2019 to 2020 aiming to analyse the prevalence of abuse and assess treatment adherence according to this variable. We used the Abuse Assessment Screen tool, the simplified medication adherence questionnaire and the medication possession ratio to assess outcomes.. Of the 161 included PLHIV, 53 (32.9%) had suffered abuse (27 emotional abuse, 6 physical abuse, 3 sexual abuse, 13 emotional and physical abuse, 4 unknown type). Seven (4.3%) had suffered abuse in the last year (5 emotional, 2 physical). Abuse had lasted a median of 48 months (interquartile range 12-81). HIV status was considered as a cause of violence by 9.4% of victims. In the multivariable analysis, only abuse was independently associated with non-adherence [adjusted odds ratio (aOR) 3.92; 95% confidence interval (CI) 1.80-8.84;

Identifiants

pubmed: 36169405
doi: 10.1080/09540121.2022.2125929
doi:

Types de publication

Observational Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1443-1451

Auteurs

Jara Llenas-García (J)

Internal Medicine, Hospital Vega Baja-FISABIO, Orihuela, Spain.
Clinical Medicine Department, Universidad Miguel Hernández, Elche, Spain.

Mar Masiá (M)

Clinical Medicine Department, Universidad Miguel Hernández, Elche, Spain.
Infectious Diseases Unit, Hospital General Universitario de Elche-FISABIO, Elche, Spain.

Reyes Pascual Perez (R)

Clinical Medicine Department, Universidad Miguel Hernández, Elche, Spain.
Infectious Diseases Unit, Hospital General Universitario de Elda-FISABIO, Elda, Spain.

Inmaculada González-Cuello (I)

Internal Medicine, Hospital Vega Baja-FISABIO, Orihuela, Spain.

Vanesa Agulló Re (V)

Clinical Medicine Department, Universidad Miguel Hernández, Elche, Spain.
Infectious Diseases Unit, Hospital General Universitario de Elche-FISABIO, Elche, Spain.

Mónica Romero Nieto (M)

Clinical Medicine Department, Universidad Miguel Hernández, Elche, Spain.
Infectious Diseases Unit, Hospital General Universitario de Elda-FISABIO, Elda, Spain.

María Amat Díaz (M)

Farmacology Department, Hospital General Universitario de Elda-FISABIO, Elda, Spain.

Sergio Padilla Urrea (S)

Clinical Medicine Department, Universidad Miguel Hernández, Elche, Spain.
Infectious Diseases Unit, Hospital General Universitario de Elche-FISABIO, Elche, Spain.

Francisco José Rodríguez Lucena (FJ)

Farmacology Department, Hospital Vega Baja-FISABIO, Orihuela, Spain.

Philip Wikman-Jorgensen (P)

Internal Medicine, Hospital Universitario San Juan de Alicante-FISABIO, Sant Joan d'Alacant, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH